Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for December 2007. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Urinary Marker Linked to Graves Ophthalmopathy
TUESDAY, Dec. 11 (HealthDay News) -- In patients with Graves ophthalmopathy, the most frequent extrathyroidal manifestation of Graves disease, a marker of oxidative stress is high with active disease and drops after treatment with corticosteroids, according to a report in the December issue of the Archives of Ophthalmology.
Abstract
Full Text (subscription or payment may be required)
Cytomegalovirus Retinitis Is Neglected HIV Complication
MONDAY, Dec. 3 (HealthDay News) -- In developing nations, cytomegalovirus (CMV) retinitis is a commonly overlooked but highly treatable complication of HIV infection, according to a report published in the December issue of PLoS Medicine.
Full Text
